SecSonar.com

Senti Biosciences, Inc. (SNTI)

Senti Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Senti Biosciences, Inc. (SNTI) is a Biotechnology company based in US with a market capitalization of $25.5M. Free cash flow was negative at -$43.6M. This page tracks SNTI's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 34 employees · IPO May 26, 2021

Valuation

Valuation & price

$1.01 · as of May 17, 2026 · -57.7% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

4.56

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$2.39$1.59$0.79Jul 25Dec 25Jul 26Jul 7, 25$2.21Jul 9, 25$2.35Jul 11, 25$2.13Jul 15, 25$1.88Jul 17, 25$2.01Jul 21, 25$1.98Jul 23, 25$2.05Jul 25, 25$1.93Jul 29, 25$1.80Jul 31, 25$1.70Aug 4, 25$1.74Aug 6, 25$1.69Aug 11, 25$1.52Aug 13, 25$1.54Aug 15, 25$1.52Aug 19, 25$1.60Aug 21, 25$1.59Aug 25, 25$1.59Aug 27, 25$1.56Aug 29, 25$1.47Sep 3, 25$1.45Sep 5, 25$1.39Sep 9, 25$1.30Sep 11, 25$1.38Sep 16, 25$1.39Sep 18, 25$1.39Sep 22, 25$1.39Sep 24, 25$1.41Sep 26, 25$1.39Sep 30, 25$1.41Oct 2, 25$1.52Oct 6, 25$1.67Oct 8, 25$1.78Oct 10, 25$1.69Oct 14, 25$2.08Oct 16, 25$2.18Oct 21, 25$2.05Oct 23, 25$2.00Oct 27, 25$2.24Oct 29, 25$2.15Oct 31, 25$2.03Nov 4, 25$1.81Nov 6, 25$1.81Nov 10, 25$1.93Nov 12, 25$1.89Nov 14, 25$1.61Nov 18, 25$1.71Nov 20, 25$1.81Nov 25, 25$2.08Nov 28, 25$2.23Dec 2, 25$2.10Dec 4, 25$2.22Dec 8, 25$2.39Dec 10, 25$1.49Dec 12, 25$1.31Dec 16, 25$1.25Dec 18, 25$1.17Dec 22, 25$1.22Dec 24, 25$1.15Dec 29, 25$1.06Jan 2, 26$1.10Jan 6, 26$1.10Jan 8, 26$1.08Jan 12, 26$1.12Jan 14, 26$1.10Jan 16, 26$1.03Jan 21, 26$1.08Jan 23, 26$1.08Jan 27, 26$1.06Jan 29, 26$1.02Feb 2, 26$1.01Feb 4, 26$0.90Feb 9, 26$0.91Feb 11, 26$0.87Feb 13, 26$0.83Feb 18, 26$0.92Feb 20, 26$0.86Feb 24, 26$0.93Feb 26, 26$0.98Mar 2, 26$0.93Mar 4, 26$0.95Mar 6, 26$0.96Mar 10, 26$0.99Mar 12, 26$1.00Mar 17, 26$0.98Mar 19, 26$0.90Mar 23, 26$0.90Mar 25, 26$0.88Mar 27, 26$0.79Mar 31, 26$0.81Apr 2, 26$0.86Apr 7, 26$0.86Apr 9, 26$0.87Apr 13, 26$0.90Apr 15, 26$0.94Apr 17, 26$1.10Apr 22, 26$1.14Apr 24, 26$1.09Apr 28, 26$0.96Apr 30, 26$0.92May 4, 26$0.94May 6, 26$0.97May 8, 26$0.99May 12, 26$0.97May 14, 26$1.04May 18, 26$0.94May 20, 26$0.98May 22, 26$0.99May 28, 26$1.00Jun 1, 26$0.98Jun 3, 26$0.98Jun 5, 26$0.97Jun 9, 26$0.91Jun 11, 26$0.98Jun 15, 26$0.97Jun 17, 26$0.95Jun 22, 26$0.97Jun 24, 26$1.08Jun 26, 26$1.09Jul 2, 26$1.07
$0.7752-week range$2.39
Loading valuation history…

Fundamentals

Key fundamentals

$25.5M

Market cap

—

Revenue growth (YoY)

-16431.8%

Gross margin

-$43.6M

Free cash flow (USD)

$12.5M

Net debt

4791.9%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$85.0KFY 2020$394.0KFY 2021$2.3MFY 2022$3.3MFY 2023$2.0MFY 2024$0.00FY 2025$22.0K
$85K$22K

Free cash flow by year

2019 → 2025

FY 2019$-20.4MFY 2020$-25.3MFY 2021$-40.2MFY 2022$-76.3MFY 2023$-64.4MFY 2024$-41.4MFY 2025$-43.6M
-$20.4M-$43.6M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2025-16431.8%
100.0%-16431.8%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last reported: May 14, 2026 (EPS $-0.36)

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • FinancingSecurities RegistrationJun 18, 2026Filing
  • 8-K eventSenior Secured Convertible Note IssuedMay 26, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventConvertible Note IssuanceMay 1, 2026Filing
  • Annual report10-K FiledApr 29, 2026Filing
  • 8-K eventHolding Company ReorganizationApr 1, 2026Filing

Questions

Frequently asked questions

What is Senti Biosciences, Inc.'s market cap?

Senti Biosciences, Inc. (SNTI) has a market capitalization of $25.5M.

What is SNTI's P/E ratio?

A meaningful P/E ratio is not available for SNTI — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is SNTI's price-to-book (P/B) ratio?

SNTI trades at 4.56 times book value per share.

When did Senti Biosciences, Inc. last report earnings?

SNTI last reported earnings on May 14, 2026; the next date is not yet scheduled.

Are insiders buying SNTI stock?

SEC Form 4 filings show no open-market insider buys at Senti Biosciences, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

EVAX

Evaxion Biotech A/S

$25.8M

ALLR

Allarity Therapeutics, Inc.

$26M

CELU

Celularity Inc.

$23.6M

DYAI

Dyadic International, Inc.

$27.9M

BRNS

Barinthus Biotherapeutics plc

$27.9M

IGC

IGC Pharma, Inc.

$28.7M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.